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The coefficient of variation for the partial body activation technique used in the present study was assessed by repeated measurements of anatomical specimens and for clinical studies is between 4% and 5% . The technique may be a more sensitive indicator of the rate of progression of or improvement in renal bone disease than either skeletal radiography or photon absorption by a radius (Catto et al., 1973 b) . Thus it was thought that this method of activation analysis might be of value in assessing the efficacy of loc-OHCC in promoting the remineralization of diseased bone.
The three patients in this study were selected from a group of patients on maintenance haemodialysis currently being investigated by activation analysis; selection was based on both the histological features of osteomalacia observed in the bone biopsy samples and the rapid rate of skeletal demineralization quantified by the activation technique during the 18 months before treatment started (see fig.) . Treatment with la-OHCC has now been evaluated for three months; the reversal of the demineralizing process in all three patients studied is a significant result (table III) .
The patients, who all received oral calcium supplements, ingested only relatively small quantities of calcium in their usual diets. This has been noted previously in patients with chronic renal failure (Coburn et al., 1973) . Brickman et al. (1972) reported that 2-5 [tg synthetic 1,25-dihydroxycholecalciferol given parenterally to four patients with renal insufficiency increased calcium absorption from the gastrointestinal tract. Similar results were obtained when 1 oc-OHCC was administered intravenously in a daily dose of 10 to 30 ,ug (Chalmers et al., 1973) and by mouth in a dose of 25 ,ug a day (Peacock et al., 1974) . We have shown that la-OHCC in a dose of only 1 to 2 ,ug daily is effective in promoting both calcium absorption from the gastrointestinal tract and deposition of calcium in bone.
In case 3, in which the largest increase in calcium absorption on treatment with 1 a-OHCC was recorded, symptomatic hypercalcaemia developed. The (Studd, 1973 (Craft, 1972; Kelly et al., 1973) . Oral agents are easier to administer than intravenous preparations, do not require pump equipment, and allow the midwife more time for nursing and for monitoring both mother and fetus.
With the introduction of a stable tablet preparation of prostaglandin E2 (PGE2; Prostin E2 dinoprostone) a prospective study was designed to determine its place in the active management of labour.
Materials and Methods
All patients undergoing induction of labour who consented were entered into the trial provided that the following criteria were met: the fetel membranes were intact, the fetus was alive, and the patient was not in labour.
The treatment groups were allotted on a fortnightly basis, the inductions one week being accelerated with PGE2 tablets and in the other week with intravenous oxytocin. The first week's treatment was chosen at random.
Induction was performed by low amniotomy followed by PGE, or oxytocin.
PGE, was administered in either constant dosage or incremental dosage. With the first of these the patient received 0 5 mg (1 tablet) PGE, at amniotomy and hourly thereafter throughout labour. With the incremental dosage the patient was given 0.5 mg PGE, at amniotomy and a further 0 5 mg one hour later; two hours after amniotomy she was given 1 mg (2 tablets), and this was repeated at three hours. In this manner the dosage was increased by 0 5 mg every second hourly dose until a maximum of 2 mg (4 tablets) was reached six hours after amniotomy, and this dosage was continued hourly throughout labour.
Oxytocin was given intravenously either with a Cardiff pump or by conventional gravity-feed infusion starting at 2 mU/min and doubling the dose every quarter of an hour.
With both incremental regimens enough drug was given to produce adequate uterine contractions and the dosage then continued at that level.
The following observations were made: the Bishop score of the cervix at amniotomy (Bishop, 1964) , the time interval between amniotomy and regular contractions, the time interval between amniotomy and full dilatation of the cervix, the Apgar score at one and three minutes, any third-stage complications, and any side effects of the uterine stimulants.
Patients were withdrawn from the trial if they suffered from nausea which failed to respond to metoclopramide 10 mg intramuscularly, if vomiting occurred twice in any half-hour, or if they developed diarrhoea.
Induction was deemed to have failed when the cervix did not reach 6 cm of dilatation within 24 hours of amniotomy.
Results

EFFECT ON UTERINE ACTIVITY
Of the 151 patients studied 132 reached 6 cm or more of cervical dilatation within 24 hours of amniotomy. The overall success rate was highest in the oxytocin group and lowest in patients on the constant dosage PGE,. The difference in success rate was most marked in primigravid patients and those with a low Bishop score ("the unfavourable cervix"). In each case both prostaglandin regimens were inferior to oxytocin (table I) .
Details of the failures are set out in table II. Neither of the failed cases in which oxytocin was used could be attributed to the method of uterine stimulation. The caesarean section rate in the series was 5-3%.
Those patients in whom labour was successfully stimulated did equally well whether the escalating PGE2 dosage regimen or oxytocin was used, and there was a statistically significant difference (P <0-001) between these two groups and the patients on the constant PGE2 dosage. Parous patients and those with a Bishop score of 6 or over fared significantly better (P <0-001 and P <0-001 respectively) than the primigravid patients and those with a low Bishop score respectively whatever method of stimulation was tested (table III) . .l The interval between amniotomy and the onset of regular contractions showed a similar pattern, with little difference between the escalating PGE, dosage regimen and oxytocin; patients in both these groups exhibited a more favourable trend than that in patients on the constant PGE2 dosage (table IV) .
FETAL STATE There was no difference in the Apgar scores of the infants at one and three minutes. There was one unexplained intrapartum fetal death in the incremental PGE, group but no association with the method of uterine stimulation could be shown. Induction was performed at 41 weeks because of a previous twin stillbirth. The first stage of labour lasted nine hours. The second stage lasted 15 minutes, during which the fetal heart was not heard, and a 4150-g infant was delivered which could not be resuscitated. The necropsy report was: "Intrapartum death, no cause found."
SIDE EFFECTS
On the constant dose regimen of PGE, five patients (8 8%)
were nauseated but none vomited, whereas during the administration of the escalating regimen one patient was nauseated and four vomited (11 6%). Two patients (39%) were nauseated with oxytocin. No patient had diarrhoea. There was no difference in the rate of third stage of labour complications between the three groups.
REACTIONS OF NURSING STAFF
The midwifery staff generally commented favourably on the escalating PGE2 dosage and appreciated the ease of administration of the tablets and the simplicity of the regimen.
Discussion
It is now generally accepted that artificial rupture of the membranes followed by intravenous oxytocin in rapidly escalating dosage is an efficient and rapid method of inducing labour and ensuring the delivery of a healthy infant. . The advent of oral prostaglandin tablets with their greater ease of administration has raised the question whether oxytocin is the optimal agent for uterine stimulation.
Oral prostaglandins E2 and F2a have been used to induce labour (Karim, 1971; Karim and Sharma, 1971; Barr and Naismith, 1972; Craft, 1972) but only as a fluid preparation, which needs to be freshly mixed and diluted using scrupulously cleaned glassware and syringes. In this study the more stable tablets of PGE2 were compared with intravenous oxytocin for uterine stimulation. The constant dose regimen of PGE2 had no advantage over intravenous oxytocin. The escalating regimen, however, though its success rate was not as high overall, had a similar performance to that of intravenous oxytocin in parous patients and those with a favourable Bishop score. It has the advantage of oral administration and the disadvantage of higher cost. The increased efficacy of the escalating dosage regimen of PGE2 confirms the findings of Friedman and Sachtleben (1974) .
We recommend the use of intravenous oxytocin as the method of choice in primigravid patients and those with an unfavourable cervix. In other patients the escalating dosage regimen of PGE2 and intravenous oxytocin have a similar efficacy. Ease of administration, availability of Cardiff pumps, patients' attitude, and relative cost are factors which may influence the clinician's choice of uterine stimulant after low amniotomy.
